NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025
NEXGEL (NASDAQ: NXGL), a leading provider of medical and over-the-counter products specializing in ultra-gentle, high-water-content hydrogels, has announced its participation in the upcoming Webull Consumer Virtual Webinar.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
NEXGEL (NASDAQ: NXGL), a leading provider of medical and over-the-counter products specializing in ultra-gentle, high-water-content hydrogels, has announced its participation in the upcoming Webull Consumer Virtual Webinar. The company's Chief Executive Officer, Adam Levy, will deliver a presentation on February 18, 2025, at 2:40 p.m. ET.
Investors interested in attending can access the webinar through the provided Webull zoom registration link. For those seeking one-on-one meetings with CEO Adam Levy, arrangements can be made through Webull representatives or by contacting KCSA Strategic Communications via email at NEXGEL@KCSA.Com.
Details
News Market Reaction – NXGL
The recorded move for NXGL in the trading session of this news was +5.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Webull Consumer Virtual Webinar on February 18, 2025.
Webull Consumer Virtual Webinar Details:
Presentation: Tuesday, February 18th at 2:40 p.m. ET
Webcast: https://webull.zoom.us/webinar/register/WN_701cgEm7QqGevVjnzABK0Q
To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at Webull or email KCSA Strategic Communications at NEXGEL@KCSA.Com.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.